Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Physicians face increasing metabolic, CV complications in the treatment of HIV patients
• Atypical femur fracture risk high for bisphosphonate users, study found
• Consensus group calls for standardization of testosterone testing
• Exenatide produced modest weight loss in obese women without diabetes
• FDA approved next-generation risedronate
• FDA requests withdraw of sibutramine from U.S. market
• FDA requires more data before approving once-weekly exenatide
• Follicle-stimulating hormone not shown to regulate postmenopausal bone resorption
• FRAX: A major advance for evaluating osteoporosis, but limitations exist
• Geography, race influence sex steroid levels in older men
• HT increased CHD risk in women with metabolic syndrome
• Investigational drug reduced bone resorption markers, increased BMD
• One-year lifestyle intervention with diet plus initial or delayed physical activity beneficial for severely obese adults
• Postmenopausal osteoporosis screening not in line with current guidelines, study found
• Primary ovarian insufficiency is not early menopause
• Screening, treating osteoporosis different for men vs. women
• Short-term HT suspension related to greater sleep disturbance
• Trend of rising hip fracture rates in East attributed to ‘Westernization’
• Weight-loss program with free prepared meals effectively promoted weight loss
• Zoledronic acid may provide fracture protection in postmenopausal osteoporosis
• The ‘other’ possible consequence of unrecognized severe hypoglycemia Mary M. Austin
• Post-gastric bypass hypoglycemia: A serious complication of bariatric surgery Dawn Belt Davis, MD, PhD
• Carcinoid tumor and bowel obstruction Varsha Vimalananda, MD; Stephanie L. Lee, MD, PhD, ECNU
• Addison’s disease increases risk for adverse pregnancy outcomes
• Number of new diabetes cases expected to double by 2050
• Chronic effects of metformin on vitamin B12 James R. Taylor, PharmD, CDE